TABLE 5.
Patients that developed ischemic cholangiopathy
| Recipient age/gender | Cause of liver disease/MELD | Tx year | Donor age/BMI | Local vs import | Flush | WIT(min) | aWIT(min) | DHT(min) | CIT(h) | Disposition |
|---|---|---|---|---|---|---|---|---|---|---|
| 59 F | ALD/34 | 2006 | 49/26.3 | Import | HTK | 20 | 18 | 19 | 7.76 | Retransplanted. Expired. |
| 56 M | HBV/7 | 2007 | 44/28.6 | Local | HTK | 27 | 22 | 24 | 6.93 | Retransplanted. Alive. |
| 63 M | NASH/15 | 2008 | 34/20.5 | Local | HTK | 26 | 18 | 41 | 6.53 | Retransplanted. Alive. |
| 42 Ma | ALD/27 | 2009 | 40/36.5 | Local | UW | 17 | 11 | 26 | 5.93 | Biliary interventions. Expired. |
| 70 F | HCV/12 | 2010 | 29/27.0 | Local | UW | 25 | 24 | 33 | 6.00 | Biliary interventions. Alive. |
| 48 F | ALD/16 | 2011 | 31/21.6 | Local | UW | 18 | 15 | 22 | 5.57 | Biliary interventions. Alive. |
| 41 F | HBV/fulminant | 2012 | 25/32.0 | Local | UW | 19 | 18 | 24 | 4.05 | Biliary interventions. Expired. |
| 55 M | HCV/18 | 2012 | 29/28.8 | Import | UW | 26 | 25 | 36 | 6.28 | Retransplanted. Alive. |
| 51 M | NASH/20 | 2013 | 28/32.0 | Import | UW | 18 | 16 | 17 | 4.07 | Biliary interventions. Expired. |
| 53 F | NASH/22 | 2013 | 23/24.5 | Local | UW | 25 | 20 | 21 | 3.45 | Biliary interventions. Alive. |
| 44 F | ALD/35 | 2015 | 28/25.2 | Import | UW | 25 | 24 | 19 | 3.62 | Retransplanted. Expired. |
| 44 M | ALD/29 | 2016 | 29/46.4 | Import | HTK | 23 | 21 | 30 | 8.33 | Biliary interventions. Alive. |
| 65 M | ALD/26 | 2017 | 35/24.8 | Import | HTK | 40 | 10 | 37 | 5.73 | Biliary interventions. Alive. |
| 54 M | ALD/16 | 2017 | 50/32.3 | Import | UW | 23 | 22 | 25 | 5.35 | Retransplanted. Expired. |
aThis patient underwent a simultaneous kidney and liver transplant.
ALD, alcoholic liver disease; aWIT, agonal warm ischemic time; BMI, body mass index; CIT, cold ischemic time; DHT, donor hepatectomy time; F, female; HBV, hepatitis B virus; HCV, hepatitis C virus; HTK, histidine-tryptophan-ketoglutarate solution; M, male; MELD, model for end-stage liver disease; NASH, nonalcoholic steatohepatitis; Tx, transplant; UW, University of Wisconsin solution; WIT, donor warm ischemic time.